Salarius Pharmaceuticals ... (SLRX)
NASDAQ: SLRX
· Real-Time Price · USD
5.95
0.19 (3.30%)
At close: Aug 27, 2025, 3:59 PM
5.85
-1.68%
Pre-market: Aug 28, 2025, 09:23 AM EDT
Salarius Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -957.83K | -1.71M | -1.46M | -972.12K | -1.42M | -1.72M | -881.8K | -2.44M | -3.88M | -5.34M | -6.37M | -14.41M | -4.72M | -6.11M | -4.1M | -3.74M | -3.07M | -1.85M |
Depreciation & Amortization | 1.11K | 1.11K | 1.11K | 1.1K | 1.11K | 1.11K | 1.1K | 5.61K | 1.67K | 1.67K | 1.67K | 1.67K | -1.46K | 4.8K | 4.8K | 4.8K | 4.8K | 4.79K |
Stock-Based Compensation | 23.16K | 33.53K | 51.05K | 60.01K | 85.17K | 77.51K | 85.38K | 112.66K | 123.46K | 203.34K | 145.51K | 137.87K | 199.53K | 313.9K | 145.89K | 130.32K | 147.46K | 135.38K |
Other Working Capital | -12.06K | 238.53K | -101.93K | 8K | 360.46K | 171.62K | -230.13K | -456.29K | 634.82K | -141.74K | 372.61K | -264.27K | 804.99K | 131.5K | 489.23K | -638.77K | 492.27K | -610.6K |
Other Non-Cash Items | n/a | n/a | n/a | 103.02K | n/a | n/a | 573.37K | 130K | -94.09K | -1.9M | -1.88K | 8.87M | n/a | 1.99M | -39.49K | -9.07K | -42.19K | 46.05K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -573.37K | n/a | 94.09K | 1.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 71.27K | 493.18K | 669.26K | -548.69K | 265.97K | 282.72K | -715.91K | -1.55M | -664.27K | 1.97M | 1.51M | -336.74K | 900.65K | 281.8K | 1.27M | 2.03M | -210.48K | -1.06M |
Operating Cash Flow | -862.3K | -1.18M | -742.52K | -1.36M | -1.07M | -1.35M | -1.51M | -3.75M | -4.42M | -3.17M | -4.71M | -5.74M | -3.62M | -3.52M | -2.72M | -1.58M | -3.17M | -2.72M |
Capital Expenditures | -4 | 4.00 | n/a | n/a | n/a | -5 | n/a | -4 | n/a | n/a | n/a | n/a | n/a | -1.5M | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.5M | n/a | n/a | n/a | n/a |
Debt Repayment | -112.23K | -109.64K | -106.98K | -69.88K | -116.86K | -172.79K | -169.45K | -111.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -191.4K | -285.63K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -85.69 | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -487.9K | 2.00 | n/a | n/a | 28.5M |
Financial Cash Flow | -141.2K | 545.57K | -106.98K | 1.37M | -28.19K | -172.75K | -169.45K | -211.83K | 6.68M | 336.68K | n/a | -85.69K | 2.07M | n/a | 31.26K | 406.36K | -358.12K | 28.22M |
Net Cash Flow | -1M | -636.15K | -849.5K | 11.21K | -1.1M | -1.53M | -1.68M | -3.96M | 2.27M | -2.83M | -4.71M | -5.83M | -1.55M | -5.02M | -2.69M | -1.18M | -3.53M | 25.49M |
Free Cash Flow | -862.3K | -1.18M | -742.52K | -1.36M | -1.07M | -1.35M | -1.51M | -3.75M | -4.42M | -3.17M | -4.71M | -5.74M | -3.62M | -5.02M | -2.72M | -1.58M | -3.17M | -2.72M |